What Is YD Bio Limited (YDES) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on YD Bio Limited at its current price of $2.27. The composite intrinsic value is estimated at $2.29 (+1.1% average return), with 6 models flagging overvaluation risk. The most optimistic model, ML-RIV, places fair value at $6.55 (+188.6%), while Regime Cross — the most conservative — estimates $0.10 (-95.6%). This +284.2% gap reflects genuine analytical uncertainty about YD Bio Limited's intrinsic worth.
What Do the Models Say About YDES?
10 of 13 models are currently active for YDES. Of these, 4 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates YDES's intrinsic value at $0.53, implying -76.7% downside from the current price. See which stocks rank higher →
How Does YDES Rank in Services-Medical Laboratories?
Among 24 Services-Medical Laboratories stocks, YDES ranks #22 by Quality of Company score. CirclFi's QOC score of 2.5/10 evaluates 32 fundamental signals. A score of 2.5 signals below-average fundamentals.
YD Bio Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is YDES a Value Trap?
The Value Trap algorithm is not active for YDES. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for YD Bio Limited. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, YD Bio Limited is rated at 2.5/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.
The gap between the most bullish and bearish model spans +284.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every YDES valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across YDES's 10 active models, average confidence is 8%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad